PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+3.03%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$751M
AUM Growth
-$32.5M
(-4.2%)
Cap. Flow
+$3.19M
Cap. Flow
% of AUM
0.42%
Top 10 Holdings %
Top 10 Hldgs %
35.59%
Holding
104
New
11
Increased
46
Reduced
31
Closed
15
Top Buys
| 1 |
Gilead Sciences
GILD
|
$22.7M |
| 2 |
Stryker
SYK
|
$17.9M |
| 3 |
McKesson
MCK
|
$13.1M |
| 4 |
Viridian Therapeutics
VRDN
|
$12.7M |
| 5 |
Edwards Lifesciences
EW
|
$10.8M |
Top Sells
| 1 |
Teleflex
TFX
|
$23.8M |
| 2 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$16.4M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$12.7M |
| 4 |
Boston Scientific
BSX
|
$9.81M |
| 5 |
Eli Lilly
LLY
|
$9.43M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nuvalent
NUVL
$5.72B
| $1.85M | 0.25% |
23,588
+188
| +0.8% | +$14.7K |
|
77
Ironwood Pharmaceuticals
IRWD
$175M
| $1.81M | 0.24% |
408,535
-46,942
| -10% | -$208K |
|
78
Annexon
ANNX
$225M
| $1.7M | 0.23% |
330,849
+2,236
| +0.7% | +$11.5K |
|
79
Oscar Health
OSCR
$4.72B
| $1.68M | 0.22% |
125,000
-125,000
| -50% | -$1.68M |
|
80
BioCryst Pharmaceuticals
BCRX
$1.72B
| $1.63M | 0.22% |
216,881
-247,167
| -53% | -$1.86M |
|
81
Pulmonx
LUNG
$68.5M
| $1.41M | 0.19% |
207,853
+1,409
| +0.7% | +$9.57K |
|
82
Reviva Pharmaceuticals
RVPH
$30.3M
| $931K | 0.12% |
514,273
+2,071
| +0.4% | +$3.75K |
|
83
Ardelyx
ARDX
$1.56B
| $901K | 0.12% |
177,794
+50,854
| +40% | +$258K |
|
|
THRD
84
DELISTED
Third Harmonic Bio
THRD
| $892K | 0.12% |
86,707
-151,113
| -64% | -$1.55M |
|
85
Entera Bio
ENTX
$95M
| $877K | 0.12% |
413,732
+2,656
| +0.6% | +$5.63K |
|
|
CBLL
86
CeriBell, Inc. Common Stock
CBLL
$430M
| $828K | 0.11% |
+32,002
| New | +$828K |
|
|
CLYM
87
Climb Bio, Inc. Common Stock
CLYM
$156M
| $523K | 0.07% |
290,491
+11,716
| +4% | +$21.1K |
|
88
VYNE Therapeutics
VYNE
$7.89M
| $512K | 0.07% |
152,973
-50,000
| -25% | -$168K |
|
|
EDAP
89
EDAP TMS
EDAP
$89.7M
| $342K | 0.05% |
154,832
| – | – |
|
90
AnaptysBio
ANAB
$607M
| – | – |
-138,100
| Closed | -$4.63M |
|
91
Applied Therapeutics
APLT
$71.3M
| – | – |
-907,294
| Closed | -$7.71M |
|
|
AVDL
92
Avadel Pharmaceuticals
AVDL
$1.42B
| – | – |
-254,827
| Closed | -$3.34M |
|
93
Elanco Animal Health
ELAN
$8.61B
| – | – |
-127,812
| Closed | -$1.88M |
|
94
ESSA Pharma
EPIX
$11M
| – | – |
-345,902
| Closed | -$2.1M |
|
95
Esperion Therapeutics
ESPR
$492M
| – | – |
-903,140
| Closed | -$1.49M |
|
|
96
Teleflex
TFX
$5.7B
| – | – |
-96,144
| Closed | -$23.8M |
|
97
TG Therapeutics
TGTX
$4.96B
| – | – |
-126,471
| Closed | -$2.96M |
|
98
Alpha Teknova
TKNO
$224M
| – | – |
-251,026
| Closed | -$1.21M |
|
99
X4 Pharmaceuticals
XFOR
$81.7M
| – | – |
-27,291
| Closed | -$548K |
|
|
LENZ
100
LENZ Therapeutics
LENZ
$1.13B
| – | – |
-139,357
| Closed | -$3.31M |
|